Inventor · disambiguated record
John Liddle
Also filed as: LIDDLE JOHN
33 granted patents·22 pending applications·148 citations·filing 2001–2024
97Inventor score
Files withGLAXO GROUP LTD18GLAXOSMITHKLINE IP DEV LTD9BAMBOROUGH PAUL4ATKINSON FRANCIS LOUIS3BORTHWICK ALAN DAVID3
Top patents by PatentIndex Score
55 records- 0193US7919492B2CompoundsGLAXO GROUP LTD·Filed 2010·Granted Apr 5, 2011·13 cites·4 claims
- 0293US7550462B2Piperazinediones as oxytocin receptor antagonistsGLAXO GROUP LTD·Filed 2005·Granted Jun 23, 2009·15 cites·6 claims
- 0391US9408851B2CompoundsGLAXO GROUP LTD·Filed 2015·Granted Aug 9, 2016·6 cites·2 claims
- 0489US8937179B2Substituted diketopiperazines and their use as oxytocin antagonistsGLAXO GROUP LTD·Filed 2013·Granted Jan 20, 2015·7 cites·1 claims
- 0589US8742099B2CompoundsGLAXO GROUP LTD·Filed 2013·Granted Jun 3, 2014·7 cites·1 claims
- 0689US8357685B2Substituted diketopiperazines and their use as oxytocin antagonistsGLAXO GROUP LTD·Filed 2011·Granted Jan 22, 2013·8 cites·6 claims
- 0789US8202864B2CompoundsBORTHWICK ALAN DAVID·Filed 2011·Granted Jun 19, 2012·11 cites·4 claims
- 0888US9452169B2Substituted diketopiperazines and their use as oxytocin antagonistsGLAXO GROUP LTD·Filed 2015·Granted Sep 27, 2016·4 cites·8 claims
- 0985US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 1083US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 1182US7297792B2Pyrazolopyridines and pyrazolopyridazines as antidiabeticsSMITHKLINE BEECHAM CORP·Filed 2006·Granted Nov 20, 2007·6 cites·5 claims
- 1281US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 1380US10039755B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2017·Granted Aug 7, 2018·2 cites·9 claims
- 1479US11352372B2Benzimidamides compounds comprising an oxaborinin ringINST NAT SANTE RECH MED·Filed 2019·Granted Jun 7, 2022·2 cites·10 claims
- 1579US9932328B23-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Apr 3, 2018·2 cites·16 claims
- 1679US9833449B22-(azaindol-2-yl) benzimidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2016·Granted Dec 5, 2017·2 cites·20 claims
- 1779US9518054B22-(azaindol-2-yl) benz imidazoles as PAD4 inhibitorsGLAXO GROUP LTD·Filed 2015·Granted Dec 13, 2016·2 cites·9 claims
- 1879US8633319B27-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitorsATKINSON FRANCIS LOUIS·Filed 2011·Granted Jan 21, 2014·6 cites·11 claims
- 1979US8071594B2Substituted diketopiperazines and their use as oxytocin antagonistsLIDDLE JOHN·Filed 2004·Granted Dec 6, 2011·10 cites·2 claims
- 2078US10246447B23-(6-chloro-3-oxo-3,4-dihydro-(2H)-1,4-benzoxazin-4-yl) propanoic acid derivatives and their use as KMO inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Apr 2, 2019·2 cites·8 claims
- 2178US2024400513A1Novel compoundsUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 2277US12459906B23-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitorsDR FALK PHARMA GMBH·Filed 2022·Granted Nov 4, 2025·0 cites·18 claims
- 2376US7235566B2Pyridinone derivatives for treatment of atherosclerosisSMITHKLINE BEECHAM PLC·Filed 2004·Granted Jun 26, 2007·8 cites·20 claims
- 2475US11919856B2CompoundsUCL BUSINESS LTD·Filed 2022·Granted Mar 5, 2024·0 cites·23 claims
- 2574US11767333B2Benzimidamides compounds comprising an oxaborinin ringINST NAT SANTE RECH MED·Filed 2022·Granted Sep 26, 2023·0 cites·19 claims
- 2670US9127003B22-(azaindol-2-yl)benzimidazoles as PAD4 inhibitorsATKINSON STEPHEN JOHN·Filed 2012·Granted Sep 8, 2015·2 cites·14 claims
- 2769US7109199B2Pyrazolopyridines and pyrazolopyridazines as antidiabeticsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 19, 2006·4 cites·14 claims
- 2867US2009247541A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2009·Application pending·0 cites
- 2966US2015105387A1Substituted diketopiperazines and their use as oxytocin antagonistsGLAXO GROUP LTD·Filed 2014·Application pending·0 cites
- 3066US2014235639A1Novel compoundsGLAXO GROUP LTD·Filed 2014·Application pending·0 cites
- 3165US11352334B23-(5-chloro-2-oxobenzo[d]oxazol-3(2H)-yl) propanoic acid derivatives as KMO inhibitorsUNIV COURT UNIV OF EDINBURGH·Filed 2019·Granted Jun 7, 2022·0 cites·7 claims
- 3263US2021276952A1Novel compoundsUCL BUSINESS LTD·Filed 2019·Application pending·0 cites
- 3362US10815218B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 27, 2020·0 cites·12 claims
- 3462US2013102783A1Substituted diketopiperazines and their use as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Application pending·0 cites
- 3559US2012202811A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2012·Application pending·0 cites
- 3658US10611756B2Method of treating pancreatitis using 1,4-benzoxazine derivativesGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Apr 7, 2020·0 cites·11 claims
- 3758US2015157640A1Novel compoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 3857US10273232B23-(6-alkoxy-5-chlorobenzo[D]isoxazol-3-YL)propanoic acid useful as kynurenine monooxygenase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Apr 30, 2019·0 cites·24 claims
- 3956US8993560B2CompoundsATKINSON FRANCIS LOUIS·Filed 2012·Granted Mar 31, 2015·0 cites·14 claims
- 4055US2016318884A13-(5-chloro-2-oxobenzo[d]oxazol-3(2h)-yl) propanoic acid derivatives as kmo inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 4153US9447074B2CompoundsGLAXO GROUP LTD·Filed 2015·Granted Sep 20, 2016·0 cites·20 claims
- 4252US2019100517A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 4351US2008146606A1Novel compoundsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 4451US2008176891A1Novel compoundsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 4551US2010035917A1Pyrrolo[2,3-b]pyridin-4-yl-benzenesulfonamide compounds as 1kk2 inhibitorsBAMBOROUGH PAUL·Filed 2007·Application pending·0 cites
- 4650US2016355505A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 4747US2004063753A1Pyridinone derivatives for treatment of atherosclerosisFiled 2001·Application pending·0 cites
- 4845US2018127405A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
- 4944US10407407B2Benzoimidazole derivatives as PAD4 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Sep 10, 2019·0 cites·16 claims
- 5042US2005020832A1Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitorsFiled 2002·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Liddle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →